323 results
8-K
EX-99.1
FOLD
Amicus Therapeutics Inc
9 May 24
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
7:00am
and health benefits of breastfeeding should be considered along with the mother’s clinical need for Galafold and any potential adverse effects
8-K
EX-99.1
pcb8q wt3y7g5
28 Feb 24
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
7:02am
8-K
EX-99.1
rm7uxc
8 Jan 24
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
7:01am
S-3ASR
kaubmsi1nqo9 1qpjvv
8 Nov 23
Automatic shelf registration
5:25pm
8-K
EX-99.1
zbkz93pf1mi9 xdb4g
8 Nov 23
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
7:00am
8-K
EX-10.1
0lijexu3e
2 Oct 23
Entry into a Material Definitive Agreement
8:48am
8-K
EX-10.2
ei3yxo13skj0 ts5ea
2 Oct 23
Entry into a Material Definitive Agreement
8:48am
8-K
EX-99.1
h4rxfc
27 Sep 23
AT THE FOREFRONT OF THERAPIES FOR RARE DISEASES Corporate Overview September 2023
7:00am
8-K
EX-99.1
5pyef
15 Aug 23
Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the United Kingdom
7:00am
8-K
EX-99.1
kycx19wnxco
8 Aug 23
Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates
7:00am
8-K
zmwttbec0f3qf ek3wrq
13 Jul 23
Departure of Directors or Certain Officers
5:00pm